Afuco™ Anti-Human CRLF2 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-CRLF2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The binding compounds that specifically bind to human TSLPR, can be used in the treatment of inflammatory disorders.
Supplier Creative Biolabs
Product # AFC-175CL
Pricing Inquiry
Host Humanized
Target CRLF2
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback